Nanoscope Therapeutics
@NSTherapeutics
Followers
1K
Following
144
Media
146
Statuses
228
Developing a new generation of Optogenetic Therapy designed to restore vision lost to inherited retinal disease
Dallas, TX
Joined November 2017
Exciting news at @NSTherapeutics! Excited to welcome #retina leaders to our new Visionary Advisory Committee. Read more: #genetherapy
2
3
15
@NSTherapeutics in New Orleans this week for #ASGCT2025! We are excited to present groundbreaking research on our MCO-010 - vision restoring #genetherapy for #RP and #Stargardt. Details #ophthalmology #restorevision
3
5
30
Congratulations to Dr. Subrata Batabyal, or Director, Nonclinical Developement! We celebrate your accomplishments. Details:
2
2
20
@NSTherapeutics welcomes Ashish Patel, PhD as SVP, Sales&Marketing. Full details #genetherapy #ophthalmology #biotechnology
4
4
23
Welcome to Nanoscope Dr. Daramola!.#optogenetics #ophthalmology #genetherapy #retinitispigmentosa #stargardt.Details at
3
4
26
We are excited welcome Ramesh Arjunji, PhD, to the Nanoscope team. Details:
4
3
28
Excited that Dr. Mohapatra will present today at the Vitreo-Retinal Society-India Annual Conference. If you are there, do not miss his talk! #retinitispigmentosa #clinicaltrials #retina
3
3
17
RT @CGT_Live: ICYMI:. At 52 weeks posttreatment, patients treated in the high dose cohort showed a mean improvement of 0.337 ± 0.0829 LogMA….
0
4
0
Welcome Sunil Gupta, MD to the Nanoscope Therapeutics Inc. Board of Directors. Dr. Gupta is a nationally recognized retinal surgeon and a successful entrepreneur who brings deep experience in all phases of drug development and medical devices.
0
1
19
@NSTherapeutics leadership will be presenting at #AAO2024 later this week in Chicago. Presentations will update on MCO-010 for #RP, #Stargardts, #GA.For full details:.
1
5
33
On #WorldSightDay2024 @NSTherapeutics announces plans to submit BLA for MCO-010 to treat #Retinitispigmentosa in Q12025. #stargardt #genetherapy #ophthalmology #clinicaltrials #blindness .Details:
1
8
49
Friday in Barcelona at #Euretina2024. Prof. Jordi Mones presenting topline results from our Phase 2b/3 #ClinicalTrials of MCO-010 for #Retinitispigmentosa. Join us!
4
4
31
Today at @EURETINA Congress. Don't miss our Symposium to learn more about groundbreaking optogenetic therapies for retinal disease. #retinitispigmentosa #genetherapy #euretina2024
1
3
26
Great crowd today for @NSTherapeutics CMO Dr. Samuel Barone's presentation at Ophthalmology Futures Forum in Barcelona where he talked about our optogenetic #genetherapy pipelines for #retinitispigmentosa, #stargardt and #GA #off2024 #euretina2024 #retina
0
2
24
Dr. Peter Kaiser will present Clinical Trial Results for MCO-010 for #retinitispigmentosa at Clinical Trials on the Summit in Park City. His presentation is a 2:32pm on June 8
6
3
32
@NSTherapeutics in San Diego next week for #BIO2024. CEO Sulagna Bhattacharya serves on the BIO Board of Directors and will be making a company presentation. Nanoscope leadership team will be available for meetings. #ophthalmology Details:
1
4
23
@NSTherapeutics welcomes Khandan Baradaran, PhD to our team. Details #https://bit.ly/4bnXNHm. #biotechnology #genetherapy #fightblindness
0
2
18
SRO crowd at #ARVO2024 for Dr. Allen Ho's presentation featuring results from @NStherapeutics Phase 2b/3 #clinicaltrial of our MCO-010 #optogenetic #genetherapy for #retinitispigmentosa. @ARVOinfo #ophthalmology
0
2
28
@NSTherapeutics MCO-010 #genetherapy is featured in 6 presentations at #ARVO24 beginning Mon. 5/6 when Dr. Allen C. Ho presents 12-month results from our RESTORE trial for #retinitispigmentosa. Hope to see you there and connect at our booth #4620. #ophthalmology @OISTWEETS
0
6
30